Table 1.
Area | Treatment | Time |
|||||
---|---|---|---|---|---|---|---|
15 min |
1 h |
4 h |
|||||
% | Total | % | Total | % | Total | ||
STR | Vehicle | 91.6 ± 1.6 | 197.0 ± 21 | 90.9 ± 0.6 | 196.0 ± 2.9 | 91.8 ± 1.2 | 198.2 ± 2.1 |
E2 | 89.4 ± 0.5 | 195.2 ± 1.2 | 90.1 ± 0.9 | 195.2 ± 2.2 | 89.5 ± 1.7 | 196.1 ± 1.8 | |
MS-DB | Vehicle | 95.2 ± 0.5 | 120.6 ± 3.6 | 90.2 ± 1.1 | 119.3 ± 1.9 | 90.6 ± 1.6 | 117.3 ± 1.2 |
E2 | 92.6 ± 0.2 | 117.1 ± 2.2 | 92.6 ± 1.4 | 120.0 ± 2.6 | 91.5 ± 1.8 | 121.9 ± 2.9 | |
SI | Vehicle | 99.8 ± 0.1 | 67.2 ± 4.2 | 99.2 ± 0.2 | 70.3 ± 4.1 | 99.1 ± 0.2 | 71.2 ± 3.5 |
E2 | 97.9 ± 0.2 | 69.4 ± 5.3 | 99.1 ± 0.1 | 69.6 ± 3.9 | 99.3 ± 0.1 | 72.6 ± 3.7 |
Data in the first column of each time point demonstrate the percentage of ChAT-immunopositive neurons expressing CREB (±SEM) (%). Data in the second column of each time point demonstrate the total number of ChAT-immunopositive neurons (±SEM) (Total); n = 5-7.